Back to search
Non-target Heterologous Effects of Vaccines
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-target Heterologous Effects of Vaccines trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-target Heterologous Effects of Vaccines trials you may qualify forIn addition to protecting against measles infection, measles vaccine (MV) strengthens the individual's ability to combat infections in general - MV has benefici…
Various observational studies have reported an association between influenza vaccination and lower rates of infection with SARS-Cov-2 and less COVID-19 disease…
The world is set on eradicating measles and polio infections in the coming decade. Once both infections are under control, campaigns with measles and oral polio…
The purpose of this study is to investigate for the broad immunological effects of administering measles vaccine (MV) and diphtheria-tetanus-whole cell pertussi…
Vaccines can have non-targeted or heterologous (also called non-specific) immunological effects on the immune system i.e. effects other than inducing an immune…
It has been found that the non-live vaccine against Diphtheria, Tetanus, and Pertussis (DTP) in addition to its disease specific effects may have so called "non…